Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1978 Sep 1;78(3):810–822. doi: 10.1083/jcb.78.3.810

Unusual responses of rat hepatic and renal peroxisomes to RMI 14, 514, a new hypolipidemic agent

PMCID: PMC2110207  PMID: 29903

Abstract

RMI 14, 514 ([5-tetradecycloxy]-2-furancarboxylic acid) represents a new class of hypolipidemic agents which cause unusual ultrastructural changes in liver of male rats and in selected peroxisomal enzymes in liver and kidney of both sexes. Among the principal ultrastructural changes in peroxisomes of male rat liver were (a) cavitation and compartmentalization of the matrix, often giving the appearance of a peroxisome-within-a-peroxisome, and (b) narrow, dense extensions of canaliculi or cisterns from the periphery of the peroxisome, forming partial circlets or surrounding irregular areas of cytoplasm. The unusual enzyme responses were (a) elevation of catalase activity in liver and kidney in female rats, (b) increased activity of three hydrogen peroxide-producing oxidases (urate oxidase, L-alpha-hydroxy acid oxidase, and D-amino acid oxidase) in the liver of both sexes, and (c) elevation of activity of the last two oxidases in male kidney. The peculiar ultrastructural changes in liver peroxisomes combined with the responses of selected peroxisomal enzymes represent unusual modulations or adaptations of these organelles to a hypolipidemic agent, the effects of which have not been reported extensively.

Full Text

The Full Text of this article is available as a PDF (3.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arima K., Nose K. Studies on bacterial urate:oxygen oxidoreductase. I. Purification and properties of the enzyme. Biochim Biophys Acta. 1968 Jan 8;151(1):54–62. doi: 10.1016/0005-2744(68)90160-5. [DOI] [PubMed] [Google Scholar]
  2. Azarnoff D. L., Svoboda D. J. Microbodies in experimentally altered cells. VI. Thyroxine displacement from plasma proteins and clofibrate effect. Arch Int Pharmacodyn Ther. 1969 Oct;181(2):386–393. [PubMed] [Google Scholar]
  3. Baudhuin P., Beaufay H., De Duve C. Combined biochemical and morphological study of particulate fractions from rat liver. Analysis of preparations enriched in lysosomes or in particles containing urate oxidase, D-amino acid oxidase, and catalase. J Cell Biol. 1965 Jul;26(1):219–243. doi: 10.1083/jcb.26.1.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Essner E. Endoplasmic reticulum and the origin of microbodies in fetal mouse liver. Lab Invest. 1967 Jul;17(1):71–87. [PubMed] [Google Scholar]
  5. Fletcher M. J. A colorimetric method for estimating serum triglycerides. Clin Chim Acta. 1968 Nov;22(3):393–397. doi: 10.1016/0009-8981(68)90041-7. [DOI] [PubMed] [Google Scholar]
  6. Goldenberg H., Hüttinger M., Kampfer P., Kramar R., Pavelka M. Effect of clofibrate application on morphology and enzyme content of liver peroxisomes. Histochemistry. 1976 Feb 26;46(3):189–196. doi: 10.1007/BF02462782. [DOI] [PubMed] [Google Scholar]
  7. Gotoh M., Griffin C., Hruban Z. Effect of citrate and aminotriazole on matrical plates induced in hepatic microbodies. Virchows Arch B Cell Pathol. 1975;17(4):279–294. doi: 10.1007/BF02912855. [DOI] [PubMed] [Google Scholar]
  8. Hayashi H., Suga T., Ninobe S. Studies on peroxisomes. V. Effect of ethyl p-chlorophenoxyisobutyrate on the centrifugal behavior of rat liver peroxisomes. J Biochem. 1975 Jun;77(6):1199–1204. [PubMed] [Google Scholar]
  9. Hess R., Stäubli W., Riess W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature. 1965 Nov 27;208(5013):856–858. doi: 10.1038/208856a0. [DOI] [PubMed] [Google Scholar]
  10. Hruban Z., Gotoh M., Slesers A., Chou S. F. Structure of hepatic microbodies in rats treated with acetylsalicylic acid, clofibrate, and dimethrin. Lab Invest. 1974 Jan;30(1):64–75. [PubMed] [Google Scholar]
  11. Hruban Z., Swift H., Slesers A. Ultrastructural alterations of hepatic microbodies. Lab Invest. 1966 Dec;15(12):1884–1901. [PubMed] [Google Scholar]
  12. Lazarow P. B., De Duve C. A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci U S A. 1976 Jun;73(6):2043–2046. doi: 10.1073/pnas.73.6.2043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Legg P. G., Wood R. L. New observations on microbodies. A cytochemical study on CPIB-treated rat liver. J Cell Biol. 1970 Apr;45(1):118–129. doi: 10.1083/jcb.45.1.118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Leighton F., Poole B., Beaufay H., Baudhuin P., Coffey J. W., Fowler S., De Duve C. The large-scale separation of peroxisomes, mitochondria, and lysosomes from the livers of rats injected with triton WR-1339. Improved isolation procedures, automated analysis, biochemical and morphological properties of fractions. J Cell Biol. 1968 May;37(2):482–513. doi: 10.1083/jcb.37.2.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Novikoff P. M., Novikoff A. B., Quintana N., Davis C. Studies on microperoxisomes. 3. Observations on human and rat hepatocytes. J Histochem Cytochem. 1973 Jun;21(6):540–558. doi: 10.1177/21.6.540. [DOI] [PubMed] [Google Scholar]
  16. Parker R. A., Kariya T., Grisar J. M., Petrow V. 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids. J Med Chem. 1977 Jun;20(6):781–791. doi: 10.1021/jm00216a009. [DOI] [PubMed] [Google Scholar]
  17. Poole B., Higashi T., De Duve C. The synthesis and turnover of rat liver peroxisomes. 3. The size distribution of peroxisomes and the incorporation of new catalase. J Cell Biol. 1970 May;45(2):408–415. doi: 10.1083/jcb.45.2.408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Poole B., Leighton F., De Duve C. The synthesis and turnover of rat liver peroxisomes. II. Turnover of peroxisome proteins. J Cell Biol. 1969 May;41(2):536–546. doi: 10.1083/jcb.41.2.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. ROBINSON J. C., KEAY L., MOLINARI R., SIZER I. W. L-alpha-Hydroxy acid oxidases of hog renal cortex. J Biol Chem. 1962 Jun;237:2001–2010. [PubMed] [Google Scholar]
  20. Reddy J. K., Azarnoff D. L., Svoboda D. J., Prasad J. D. Nafenopin-induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. Absence of sex difference in response. J Cell Biol. 1974 May;61(2):344–358. doi: 10.1083/jcb.61.2.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reddy J. K., Krishnakantha T. P. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate. Science. 1975 Nov 21;190(4216):787–789. doi: 10.1126/science.1198095. [DOI] [PubMed] [Google Scholar]
  22. Reddy J. K., Krishnakantha T. P., Rao M. S. Microbody (peroxisome) proliferation in mouse kidney induced by methyl clofenapate. Virchows Arch B Cell Pathol. 1975;17(4):295–306. doi: 10.1007/BF02912856. [DOI] [PubMed] [Google Scholar]
  23. Sternlieb I., Quintana N. The peroxisomes of human hepatocytes. Lab Invest. 1977 Feb;36(2):140–149. [PubMed] [Google Scholar]
  24. Svoboda D. J., Azarnoff D. L. Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB). J Cell Biol. 1966 Aug;30(2):442–450. doi: 10.1083/jcb.30.2.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Svoboda D. J. Response of microperoxisomes in rat small intestinal mucosa to CPIB, a hypolipidemic drug. Biochem Pharmacol. 1976 Dec 15;25(24):2750–2752. doi: 10.1016/0006-2952(76)90268-9. [DOI] [PubMed] [Google Scholar]
  26. Svoboda D., Azarnoff D., Reddy J. Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands. J Cell Biol. 1969 Mar;40(3):734–746. doi: 10.1083/jcb.40.3.734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Svoboda D., Grady H., Azarnoff D. Microbodies in experimentally altered cells. J Cell Biol. 1967 Oct;35(1):127–152. doi: 10.1083/jcb.35.1.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tsukada H., Mochizuki Y., Fujiwara S. The nucleoids of rat liver cell microbodies. Fine structure and enzymes. J Cell Biol. 1966 Mar;28(3):449–460. doi: 10.1083/jcb.28.3.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tsukada H., Mochizuki Y., Konishi T. Morphogenesis and development of microbodies of hepatocytes of rats during pre- and postnatal growth. J Cell Biol. 1968 May;37(2):231–243. doi: 10.1083/jcb.37.2.231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tuchweber B., Kourounakis P., Latour J. G. Drug metabolism and morphologic changes in the liver of nafenopin-treated rats. Arch Int Pharmacodyn Ther. 1976 Aug;222(2):309–321. [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES